| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |